Company intelligence / Profile preview
Yangtze River Pharmaceutical Group
Taizhou, Jiangsu, China
- Ownership
- Private
- Employees
- ~18000
- Development stage
- Other
01
Overview
Yangtze River Pharmaceutical Group has a broad commercial portfolio of more than 300 marketed products and a pipeline of innovative programs in oncology, neurological disorders, infection, and metabolism. Several biological drugs are in clinical/preclinical studies, and key biosimilar collaborations are aiming at immunology, oncology, and ophthalmology.
- Therapeutic areas
- EndocrinologyMetabolic DisordersPsychiatryInfectious DiseasesCardiovascularOncologyNeurology
- Modalities
- Small moleculeBiologicMonoclonal antibodyTraditional Chinese medicine
- Industry
- Biotech
02
Drug pipeline
7 assets6 more assets in the full pipeline.
Request access →03
Partnerships
Mabwell (strategic biotech collaboration for biological drugs)Alvotech & CCHT Biopharmaceutical (biosimilar commercialization in China)
Beyond the preview
Go deeper on Yangtze River Pharmaceutical Group.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Licensing & deals
Full profile accessExplore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Full profile accessTrace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Full profile accessCompare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Full profile accessExplore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Full profile accessConnect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Yangtze River Pharmaceutical Group.